AB0819 FLARES AMONG PATIENTS WITH PSORIATIC ARTHRITIS (PsA) - FREQUENCY AND IMPACT ON PATIENT OUTCOMES: REAL-WORLD SURVEY IN THE US AND EUROPE
Ana‐Maria Orbai(Johns Hopkins University), Laure Gossec(Inserm), Elizabeth Holdsworth(Adelphi Group (United Kingdom)), Steven L. Peterson(Janssen (United States)), Sophie Meakin(London School of Hygiene & Tropical Medicine), Sara Bruce Wirta(Novartis (Switzerland)), S. D. Chakravarty(Janssen (United States)), Suzanne M. Grieb(Johns Hopkins University), William Tillett(Royal United Hospital Bath NHS Trust)
Cited by 1
Related Papers
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
|Annals of the Rheumatic Diseases|2020|2.8k
Effectiveness of isolation, testing, contact tracing, and physical distancing on reducing transmission of SARS-CoV-2 in different settings: a mathematical modelling study
|The Lancet Infectious Diseases|2020|960
Using a real-world network to model localized COVID-19 control strategies
|Nature Medicine|2020|277
International patient and physician consensus on a psoriatic arthritis core outcome set for clinical trials
|Annals of the Rheumatic Diseases|2016|275
Quarantine and testing strategies in contact tracing for SARS-CoV-2: a modelling study
|The Lancet Public Health|2021|243